The WATCHMAN Device can be implanted safely, enables patients to discontinue warfarin, and reduces afib stroke risk comparably to warfarin. In addition, the WATCHMAN Device demonstrated statistically superior reductions in hemorrhagic stroke, disabling stroke and cardiovascular death compared to warfarin over long-term follow-up: 85% in hemorrhagic stroke 63% in disabling stroke 56% in cardiovascular death.
Learn more about WATCHMAN at: [ Ссылка ]
